Genomic identification of significant targets in cancer (GISTIC) analysis revealed several significantly altered focal aberrations, most notably CDK6 gain (chromosome 7q21.2), OTX2 gain (14q22.3), and AXIN2 gain (17q24.1; Online Resource Table 7 and Online Resource Fig. 7). The gene discussed is OTX2; the disease is cancer.